Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term personalized cholic acid safety study in bile acid synthesis defects
NL-OMON25657Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cholic acid in Bile Acid Synthesis Defects (BASD) and Zellweger spectrum disorder (PBD-ZSD), sponsored by Amsterdam University Medical Center. Primary endpoints: Degree of suppression of endogenous bile acid synthesis, Type and number of adverse events and 1 more. Started May 2020; status: recruiting.
02
Drugs
cholic acid
03
Conditions
Bile Acid Synthesis Defects (BASD)Zellweger spectrum disorder (PBD-ZSD)
Beyond the preview
Go deeper on NL-OMON25657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25657.